These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15106307)

  • 1. [Macrolides in modern therapy of bacterial infections. Spectrum of efficacy characteristics and pharmacological activity].
    Budanov SV; Vasil'ev AN; Smirnova LB
    Antibiot Khimioter; 2003; 48(11):15-22. PubMed ID: 15106307
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do ketolides have real advantages over macrolides?].
    Muñoz Bellido JL; García-Rodríguez JA
    Rev Esp Quimioter; 2003 Sep; 16(3):273-6. PubMed ID: 14702118
    [No Abstract]   [Full Text] [Related]  

  • 3. [New therapeutic uses of the macrolides].
    Mihălţan F
    Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bacterial internalization and intracellular activity of quinolones and macrolides].
    Bellussi L; De Benedetto M; Lauriello M; Passali GC; Passali D
    Acta Otorhinolaryngol Ital; 2007 Apr; 27(2 Suppl 87):1-11. PubMed ID: 17702375
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical basis of macrolides apply in diseases of the respiratory tract].
    Płusa T
    Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New macrolide, lincosaminide and streptogramin B antibiotics.
    Kirst HA
    Expert Opin Ther Pat; 2010 Oct; 20(10):1343-57. PubMed ID: 20645886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telithromycin.
    Raja A; Lebbos J; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Sep; 3(9):733-4. PubMed ID: 15368658
    [No Abstract]   [Full Text] [Related]  

  • 8. Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.
    Drusano GL
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):150S-158S. PubMed ID: 16305286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolides and staphylococcal biofilms.
    Parra-Ruiz J; Vidaillac C; Rybak MJ
    Rev Esp Quimioter; 2012 Mar; 25(1):10-6. PubMed ID: 22488536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of macrolide resistance in Mycoplasma pneumoniae acquired during the treatment period.
    Itagaki T; Suzuki Y; Seto J; Abiko C; Mizuta K; Matsuzaki Y
    J Antimicrob Chemother; 2013 Mar; 68(3):724-5. PubMed ID: 23152478
    [No Abstract]   [Full Text] [Related]  

  • 11. [New antibacterial agents].
    Järvinen A; Valtonen V
    Duodecim; 2000; 116(24):2803-5. PubMed ID: 12077883
    [No Abstract]   [Full Text] [Related]  

  • 12. Looking for new preparations for antibacterial therapy. IV. New antimicrobial agents from the aminoglycoside, macrolide and tetracycline groups in clinical trials.
    Karpiuk I; Tyski S
    Przegl Epidemiol; 2015; 69(4):723-9, 865-70. PubMed ID: 27139351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of atypical infections and macrolide therapy in patients with asthma.
    Rollins DR; Good JT; Martin RJ
    J Allergy Clin Immunol Pract; 2014; 2(5):511-7. PubMed ID: 25213043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macrolides in pediatric practice].
    Baráibar R
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):462-5. PubMed ID: 2490475
    [No Abstract]   [Full Text] [Related]  

  • 16. [The macrolide antibiotics in treatment of skin diseases].
    Owczarek W; Paluchowska E
    Pol Merkur Lekarski; 2008 Nov; 25(149):429-31. PubMed ID: 19177782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of macrolide resistance: not in every country! [Comment on: Halpern et al. J Antimicrob Chemother 2005; 55: 748-57].
    Monnet DL; Brandt CT; Kaltoft MS; Bagger-Skjøt L; Sørensen TL; Nielsen HU; Frimodt-Møller N
    J Antimicrob Chemother; 2005 Aug; 56(2):433-4; author reply 434-5. PubMed ID: 15967766
    [No Abstract]   [Full Text] [Related]  

  • 18. [The different intake modalities of oral antibiotics].
    Maesschalck J
    J Pharm Belg; 2012 Sep; (3):4-14. PubMed ID: 23697091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin: mechanisms of action and their relevance for clinical applications.
    Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
    Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy.
    Vila J; Bonomo RA
    Future Microbiol; 2007 Feb; 2(1):9-12. PubMed ID: 17661671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.